Cathie Wood’s ARK Invest Buys Over 350,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 350,000 shares of Pfizer on August 27.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 350,000 shares of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) on Friday, as the price of this fund was up over 2% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 351,289 shares of Pfizer. At Friday’s closing price, this would have valued this purchase at roughly $16.4 million. This is only a small fraction of the total holdings. The fund is up 42% over the past 52 weeks.
Check out all the ARK Invest buys for Friday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | JD | JD.COM | 38,130 |
| ARKF | PDD | PINDUODUO | 62,767 |
| ARKF | TDOC | TELADOC HEALTH | 4,793 |
| ARKG | PFE | PFIZER | 351,289 |
| ARKG | QSI | QUANTUM-SI | 1,818 |
| ARKG | FATE | FATE THERAPEUTICS | 57,841 |
| ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 49,500 |
| ARKG | RPTX | REPARE THERAPEUTICS | 7,501 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,000 |
| ARKG | PSNL | PERSONALIS | 5,444 |
| ARKK | SGFY | SIGNIFY HEALTH | 190,400 |
| ARKK | FATE | FATE THERAPEUTICS | 114,617 |
| ARKQ | ACIC | ATLAS CREST INVESTMENT | 190,900 |
| ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 59,400 |
| ARKQ | KMTUY | KOMATSU | 17,000 |
| ARKW | GENI | GENIUS SPORTS | 69,647 |
| ARKX | PRNT | 3D PRINTING ETF | 11,293 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Contact [email protected] for any questions or corrections.




